Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

Aurora Cannabis Inc. ACB recently reported strong quarterly earnings that outpaced market expectations, despite a downturn across the cannabis sector.

Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?

NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a lifestyle and consumer packaged goods company, announces the launch of "Men's Health on Tap," a new podcast series hosted by distinguished doctors, Dr. John P. Sfakianos, MD, Associate Professor, Department of Urology at the Icahn School of Medicine, and Dr. Steven A. Kaplan, MD, Professor, Department of Urology at the Icahn School of Medicine. The podcast aims to break down stigmas around men's health and invite listeners to an open conversation about important men's health topics.

Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engage in Empowering Discussions and Break Down Stigmas Around Men's Health Topics

Canopy Growth

Cronos Group

Curaleaf Holdings, Inc.

Trulieve Cannabis Corp.

Following Donald Trump's presidential election victory Tuesday, the cannabis sector took a sharp downturn.

Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close

Shares of cannabis companies fell Wednesday after a ballot measure that would have legalized recreational marijuana in Florida failed to pass.

Cannabis Stocks Plummet After Legalization Bid Fails in Florida

Green Thumb Industries Inc.

Global Tech Industries Group, Inc.

AdvisorShares Pure US Cannabis ETF

North Dakota and South Dakota also failed in their efforts to legalize cannabis for recreational use, while a medical measure passed in Nebraska.

Cannabis stocks crater as Florida fails to garner needed votes for adult use

Shares in cannabis stocks such as Trulieve Cannabis Corp. (CSE:TRUL), Curaleaf Hldgs Inc. (CSE:CURA, OTCQX:CURLF) and Verano Holdings Corp (CSE:VRNO, OTCQX:VRNOF) tanked after Florida rejected legalization of recreational marijuana. A ballot measure, known as Amendment 3, which would have allowed adults to possess up to three ounces of marijuana, failed to obtain the required 60% of support from voters yesterday.

Cannabis stocks tank as Florida votes against recreational marijuana

As the election approaches, Canadian cannabis stocks are capturing attention, especially with potential U.S. legalization developments on the horizon. The U.S. cannabis industry is booming, with projected growth reaching $41 billion by 2025. This massive market is appealing to Canadian companies seeking new revenue streams. Florida, in particular, is considering the legalization of recreational cannabis, which could unlock significant growth for Canadian cannabis companies with existing U.S. ties. If Florida joins the ranks of legal states, Canadian companies like Tilray, Canopy Growth, and Cronos Group could capitalize on this opportunity. These stocks are increasingly appealing to investors looking to benefit from potential changes in the U.S. market.

Top Canadian Cannabis Stocks to Track as U.S. Legalization Heats Up

Intel

iRobot

Boo! These stocks have all lost more than half of their value in just five years.

3 Stocks That Have Generated Terrifying Returns for Investors Over the Past 5 Years

SNDL Inc.

Marijuana stock investors are keeping a close eye on the sector. The reason for this is all that is occurring in the sector at this time. We have companies preparing to report earnings on top of the politics surrounding the promises of the presidential election. Politics can greatly impact trading depending on the circumstances. For instance, when a politician speaks in favor of legal cannabis, it has the potential to create a rise in trading.

3 Marijuana Stocks For Today's Trader

Tilray Brands TLRY remains a cautious investment, according to Zuanic & Associates, despite its solid balance sheet and diverse global assets. With a "Neutral" rating, Zuanic views Tilray as a long-term player in the cannabis sector, though short-term uncertainties cloud its outlook.

Beyond Beer, Tilray's $1.67 Billion Market Play: Is This Cannabis Giant Still A Smart Buy?

In a fireside chat with senior analyst Pablo Zuanic on October 23, 2024, Tilray Brands TLRY CEO Irwin Simon shared insights into the company's growth strategies, highlighting profitability, U.S. market entry and the expansion of their cannabis and beverage businesses. Simon also addressed the recent quarterly performance and challenges the company faces in both domestic and international markets.

EXCLUSIVE: Tilray CEO Irwin Simon On Why US Cannabis Rescheduling Won't Change A Billion-Dollar Play

Tilray Brands (TLRY) stock price has gone nowhere in the past few months. It has found a strong support level at $1.61, where it has failed to move below since November last year.

Tilray Brands stock analysis: attractive risk/reward?

LITTLETON, Colo., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), announced today the release of its seasonal Funslinger Lager , a crisp and easy-drinking beer that's the perfect companion to kick off winter's adventures.

Breckenridge Brewery Unveils Annual Release of Funslinger Lager in Collaboration with Colorado Artist Mike Graves

LM Ericsson Telefon

HashiCorp

Hyster-Yale Materials Handling

Zoom Video

HY, HCP, TLRY, ZM and ERIC have been added to the Zacks Rank #1 (Strong Buy) List on October 18, 2024.

New Strong Buy Stocks for October 18th

Apogee Enterprises

CONSOL Energy

Invest in companies like Tilray Brands (TLRY), Consol Energy (CEIX) and Apogee Enterprises (APOG) to make the most of higher efficiency levels.

3 Must-Buy Efficient Stocks to Increase Portfolio Returns

TORONTO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, celebrates six years of cannabis legalization in Canada, marking its continued leadership as the #1 cannabis producer in the country1. Blair MacNeil, President of Tilray Canada, said, “Our success over the past six years is a testament to our unwavering commitment to our consumers and delivering exceptional products that cater to their needs.

Tilray Brands Celebrates Six Years of Cannabis Legalization in Canada with Industry-Leading Innovation in Brands and Products

Village Farms International

When looking for top marijuana stocks what would a person look for or do? Like all things, you need to do your homework. Some various sectors and companies make up the cannabis industry. Progress and success can mean better gains in the market. The cannabis industry as a whole has come a long way since it first began. Now with almost every state in the US having legal cannabis operations are growing for most companies. Also, places like Canada and certain parts of Europe have a legal cannabis industry as well.

Top Marijuana Stocks For Making Gains In The Sector

Tilray is beaten down, but that alone doesn't make it cheap.

Is Tilray Brands Stock a Buy?

Tilray's Q1 revenue missed estimates by $21 million, showing 13% year-over-year growth driven by beverage acquisitions, while cannabis revenue declined nearly 13%. The company reported a larger GAAP operating loss, but improved GAAP net loss, and a 13% decline in adjusted EBITDA, with significant cash burn and shareholder dilution. Tilray's valuation discount to Canopy Growth has narrowed, with analysts still very positive but cutting their price targets over time.

Tilray: Another Weed In The Garden

Tilray Brands (TLRY) Chief Executive Officer (CEO) Irwin Simon said the 2024 presidential election is likely to improve the legal cannabis industry in the U.S.—regardless of who wins.

Tilray CEO Bullish on Cannabis Legalization Following 2024 Election

Tilray Brands, Inc. (NASDAQ:TLRY ) Q1 2025 Earnings Conference Call October 10, 2024 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs and Communications Officer Irwin Simon - Chairman and CEO Carl Merton - CFO Denise Faltischek - Chief Strategy Officer and Head of International Blair MacNeil - President of Tilray Canada Conference Call Participants Kaumil Gajrawala - Jefferies Aaron Grey - Alliance Global Partners Matt Bottomley - Canaccord Genuity Bill Kirk - ROTH MKM Michael Lavery - Piper Sandler Pablo Zuanic - Zuanic & Associates Robert Moskow - TD Cowen Operator Thank you for joining today's conference call to discuss Tilray Brands' Financial Results for the First Quarter ended August 31, 2024. All lines have been placed on mute to prevent any background noise.

Tilray Brands, Inc. (TLRY) Q1 2025 Earnings Call Transcript

Tilray Brands (NASDAQ:TLRY) shares moved lower after the cannabis-focused consumer packaged goods firm's fiscal first quarter sales missed estimates. Revenue for the quarter ended August 31 was $200 million, up 13% year-over-year but below the consensus estimate of $218.9 million.

Tilray Brands narrows net loss but misses sales forecast for Q1

While the top- and bottom-line numbers for Tilray Brands (TLRY) give a sense of how the business performed in the quarter ended August 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Tilray Brands (TLRY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Tilray Brands, Inc. (TLRY) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.10 per share a year ago.

Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Lags Revenue Estimates

Tilray's stock gained Thursday, after the cannabis and beverage company reported a smaller loss than expected for its fiscal first quarter, although revenue came up short.

News for Tilray Brands Stock (TLRY)